The incidence of leprosy, an infectious disease that causes lumps and skin sores, has decreased by roughly 95%, but 233,000 new cases were reported in 2012.
Professor Klaus M. Leisinger is stepping down as Chairman of the Board of the Novartis Foundation for Sustainable Development (NFSD). Dr. Andrin Oswald will take on an additional role as Chairman of the Board overseeing the NFSD.
Malaria programs in sub-Saharan Africa are making progress by using insecticide-treated nets, diagnostic testing and Artemisinin-based Combination Therapy.
More than 1.5 million healthcare workers, including nurses and birthing attendants, are needed in Africa. The continent has 24% of the world’s disease burden.
Acute heart failure (AHF) is a condition where the heart cannot pump enough blood around the body. Each year 3.5 million AHF episodes occur in the US and EU.
Novartis BioCamp gives students new perspectives on healthcare challenges.
Sixty of the world’s most talented science students from around the world arrive in Basel on 25 August 2013 for the Novartis BioCamp, a three-day exploration of some of the biggest challenges and opportunities in the biotech and healthcare industries.
Following successful pilots in India, China, France and Latin America, Novartis Responsible Procurement went global on April 1, 2013.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.